Telix Pharmaceuticals (ASX:TLX) said it has opened a cyclotron facility, Telix Manufacturing Solutions, in Yokohama, Japan, according to a Thursday statement by the company.
The facility will support commercial and clinical supply as well as research and development for Telix's pipeline of radiopharmaceutical products, including Zircaix, Illuccix, and Pixclara, the statement said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.